CTRI/2020/02/023195已完成4 期
Effect of Sodium-glucose Co-Transporter 2 (SGLT2) inhibitors of Left Ventricular Mass and Diastolic Function in Type-2 Diabetes Mellitus Patients at a Tertiary Care Hospital in South India.
izams Institute of Medical Sciences0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1)Patients aged between 18 and 65 years of either sex.
- •2)Type 2 Diabetes Mellitus Patients with HbA1c >=7% <= 10%.
- •3. patients asymptomatic and without history of CVD.
- •4)Patients on stable dose of tablet metformin (1000-2500mg) plus any 2 of the folloowing durg combinations- tablet glimiperide (2-8mg), tablet gliclazide SR 30-80 mg, tablet linagliptin 5mg, tablet sitaglyptin 100mg, tablet vildagliptin 50mg, tablet tenaligliptin 20mg since last 3 months.
- •5)Patients who are SGLT2 inhibitor naïve.
排除标准
- •1)Patients on insulin and GLP-1 analogues
- •2)Patients with h/o type 1 Diabetes Mellitus, Congestive Cardiac Failure, Myocardial Infarction, Renal & Hepatic impairment.
- •3)Pregnant women and lactating mothers
- •4)Patients not willing to give informed consent and comply with study related procedures.
研究者
相似试验
已完成
不适用
Effects of sodium-glucose co-transporter 2 (SGLT2) inhibitors on biomarkers in early diabetic nephropathy in Japanese with type 2 diabetesJPRN-UMIN000021619Yokohama City University Graduate School of Medicine20
终止
不适用
Effects of Sodium Glucose Co-Transpoter-2 (SGLT-2) in diabetics with heart failureCardiovascular - Other cardiovascular diseasesMetabolic and Endocrine - DiabetesType 2 DiabetesHeart failureACTRN12618000795291Endcrinology Department, Box Hill Hospital - Eastern Health2
已完成
不适用
Effects of sodium/glucose cotransporter 2 (SGLT2) inhibitors on metabolic parameters in patients with type 2 diabetes: A chart-based analysistype 2 diabetesJPRN-UMIN000020314ational Center for Global Health and Medicine Kohnodai Hospital75
招募中
不适用
Effects of sodium-glucose co-transporter2(SGLT2) inhibitors on left ventricular systolic and/or diastolic dysfunction in Japanese type2 diabetesType2 diabetic patients with systolic and/or diastolic dysfunctionJPRN-UMIN000025841Kanagawa Cardiovascular and Respiratory Center30
尚未招募
4 期
Effects of SGLT2 Inhibitor Therapy on Pancreatic and hepatic fat content in patients of Type 2 Diabetes MellitusCTRI/2019/08/020909ASTRA ZENECA PHARMACEUTICAL INDIA